1104 related articles for article (PubMed ID: 15241527)
1. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
3. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy.
Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J
Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356
[TBL] [Abstract][Full Text] [Related]
7. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
9. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
11. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
[TBL] [Abstract][Full Text] [Related]
12. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
Nelson DF; Diener-West M; Horton J; Chang CH; Schoenfeld D; Nelson JS
NCI Monogr; 1988; (6):279-84. PubMed ID: 3281031
[TBL] [Abstract][Full Text] [Related]
13. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
[TBL] [Abstract][Full Text] [Related]
14. [Role of radiotherapy in recurrent gliomas].
Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
[TBL] [Abstract][Full Text] [Related]
19. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
[TBL] [Abstract][Full Text] [Related]
20. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]